XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.

NCT06792435 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Adenocarcinoma Metastatic
Lung Cancer (NSCLC)
Ovarian Cancer
Colorectal Cancer Metastatic
Biliary Tract Cancer
Gastric Carcinoma
Gastroesophageal Junction Adenocarcinoma

Interventions

DRUG: XNW27011
DRUG: XNW27011

Sponsor

Evopoint Biosciences Inc.